Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Rapid Antigen Detection Tests - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Rapid Antigen Detection Tests estimated at US$199.9 Million in the year 2020, is projected to reach a revised size of US$355.9 Million by 2027, growing at a CAGR of 8.6% over the period 2020-2027.
The U.S. Market is Estimated at $54 Million, While China is Forecast to Grow at 13% CAGR
The Rapid Antigen Detection Tests market in the U.S. is estimated at US$54 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$82.1 Million by the year 2027 trailing a CAGR of 13% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 7.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.
Select Competitors (Total 34 Featured):
- Abbott Laboratories
- Acumen Research Laboratories
- Beijing Tigsun Diagnostics Co. Ltd.
- Biolidics
- Biomaxima
- BioMedomics
- CTK Biotech
- Getein Biotech
- LabCorp
- ThermoFisher
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 34
For more information about this report visit https://www.researchandmarkets.com/r/7iomah